Experts analyze how Trump's drug pricing policies, including Most Favored Nation (MFN) and tariffs, reshape pharma markets and impact patient costs and access.

In contrast, the experts noted that several recent FDA approvals introduced first-in-class therapies to the oncology landscape. 1 Among these are menin inhibitors, which block the interaction between ...

UPMC's pilot program reveals how social determinants of health impact food access and blood sugar management, challenging traditional health care assumptions.

As health care policy evolves at breakneck speed, the Academy of Managed Care Pharmacy (AMCP) Nexus 2025 conference, held ...

This article provides insights into patterns of health care use following emergency department visits by high-need, high-cost patients with different types of California Medicaid primary care ...

Bispecific antibody treatments remain a promising treatment for diabetic macular edema (DME), as a new study shows that faricimab was effective and had durable results after a year of real-world ...

Ketogenic diets may modestly improve depressive symptoms, especially with ketone monitoring and very low-carbohydrate interventions. Ketogenic diets were linked to modest reductions in depressive ...

Subcutaneous therapy could be the future of non–small cell lung cancer (NSCLC) as it would decrease time needed for treatment ...

Conclusions: There is a potential mismatch between what clinicians identify as important in determining palliative care need and final eligibility determinations. Patients with dementia were less ...

Baricitinib (Olumiant; Eli Lilly), an oral Janus kinase (JAK) 1/2 inhibitor, led to significant scalp, eyelash, and eyebrow hair regrowth at 52 weeks in adolescents with severe alopecia areata, ...

Panelists discuss how RWE informs treatment and safety decisions for special populations such as patients with ECOG PS 2 with ...

Panelists examine the value of patient-reported outcomes (PROs) in helping guide therapy selection for later-line metastatic ...